NanoString Technologies provides life science tools for translational research and molecular diagnostics. The company’s technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.

NanoString’s products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2019, GeoMx DSP was launched, enabling highly multiplexed spatial profiling of RNA and protein targets in various sample types, including challenging Formalin-Fixed, Paraffin-Embedded (FFPE) tissue. The unique combination of high-plex and high-throughput spatial profiling allows researchers to rapidly and quantitatively assess the biological implications of heterogeneity within tissues and has resulted in over 60 peer-reviewed publications to date.

Continued investment in innovation has produced a robust product pipeline including the Spatial Molecular Imager that will provide highly sensitive, sub-cellular imaging of hundreds to thousands of RNAs or proteins directly from single cells within morphologically intact tissue samples. This new platform complements the high-plex, high throughput GeoMx DSP and together, these platforms will span the continuum of spatial biology applications and will serve the needs of both discovery and translational researchers.